SII, Bharat Biotech Jointly Pledge for Smooth Roll Out of COVID-19 Vaccines in India

Pune/Hyderabad: Serum Institute of India and Bharat Biotech have jointly communicated their pledge towards a smooth roll out of COVID-19 vaccines in India and globally.

In a joint statement, Adar Poonawala, CEO of SII and Dr. Krishna Ella, Chairman & Managing Director of Bharat Biotech, said that the more important task in front of them is saving the lives and livelihoods of populations in India and the world.

Vaccines are a global public health good and they have the power to save lives and accelerate the return to economic normalcy at the earliest.

Now that two COVID-19 vaccines have been issued EUA (emergency use authorization) in India , the focus is on manufacturing , supply and distribution, such that populations that need it the most receive high quality, safe and efficacious vaccines, the statement said.

“Both our Companies are fully engaged in this activity and consider it our duty to the nation and the world at large to ensure a smooth rollout of vaccines . Each of our companies continue their COVID – 19 vaccines development activities as planned”, it added.